全文获取类型
收费全文 | 2918篇 |
免费 | 336篇 |
国内免费 | 58篇 |
专业分类
耳鼻咽喉 | 15篇 |
儿科学 | 157篇 |
妇产科学 | 49篇 |
基础医学 | 431篇 |
口腔科学 | 32篇 |
临床医学 | 280篇 |
内科学 | 636篇 |
皮肤病学 | 66篇 |
神经病学 | 196篇 |
特种医学 | 480篇 |
外科学 | 281篇 |
综合类 | 58篇 |
一般理论 | 1篇 |
预防医学 | 237篇 |
眼科学 | 21篇 |
药学 | 178篇 |
中国医学 | 6篇 |
肿瘤学 | 188篇 |
出版年
2022年 | 15篇 |
2021年 | 34篇 |
2020年 | 29篇 |
2019年 | 30篇 |
2018年 | 43篇 |
2017年 | 36篇 |
2016年 | 24篇 |
2015年 | 41篇 |
2014年 | 46篇 |
2013年 | 88篇 |
2012年 | 84篇 |
2011年 | 102篇 |
2010年 | 80篇 |
2009年 | 99篇 |
2008年 | 90篇 |
2007年 | 135篇 |
2006年 | 91篇 |
2005年 | 101篇 |
2004年 | 75篇 |
2003年 | 92篇 |
2002年 | 80篇 |
2001年 | 83篇 |
2000年 | 89篇 |
1999年 | 86篇 |
1998年 | 118篇 |
1997年 | 102篇 |
1996年 | 129篇 |
1995年 | 80篇 |
1994年 | 75篇 |
1993年 | 75篇 |
1992年 | 69篇 |
1991年 | 70篇 |
1990年 | 78篇 |
1989年 | 96篇 |
1988年 | 86篇 |
1987年 | 87篇 |
1986年 | 83篇 |
1985年 | 70篇 |
1984年 | 44篇 |
1983年 | 30篇 |
1982年 | 22篇 |
1981年 | 23篇 |
1980年 | 29篇 |
1979年 | 34篇 |
1978年 | 26篇 |
1977年 | 23篇 |
1976年 | 25篇 |
1975年 | 26篇 |
1974年 | 19篇 |
1973年 | 21篇 |
排序方式: 共有3312条查询结果,搜索用时 15 毫秒
1.
2.
Uptake of iodine-123 MIBG by pheochromocytomas, paragangliomas, and neuroblastomas: a histopathological comparison 总被引:2,自引:0,他引:2
J Bomanji D A Levison W D Flatman T Horne P M Bouloux G Ross K E Britton G M Besser 《Journal of nuclear medicine》1987,28(6):973-978
The percentage uptake of [123I]metaiodobenzylguanidine (MIBG) by tumors of the paraganglion system is compared with the number of neurosecretory granules (assessed by both light and electron microscopy) in the subsequently resected tumors in six patients. Iodine-123 MIBG was injected intravenously; the tumor uptake of [123I]MIBG varied between 0.001% and 0.14% of the injected dose per gram of tumor tissue at 22 hr. The number of neurosecretory granules in tissue sections was scored on a scale of I-III. A direct proportional correlation was found between the percentage uptake of [123I]MIBG by the tumor and the number of neurosecretory granules in the tissue sections but not with plasma or urinary catecholamines. This technique for imaging reflects the storage status of the tumor better than plasma and urinary catecholamine measurements. 相似文献
3.
The requirements, problems and progress of radioimmunotherapy in the management of certain malignancies are described. The future prospects using a two- or three-stage approach are promising. 相似文献
4.
Israel Liberzon Stephan F Taylor K Luan Phan Jennifer C Britton Lorraine M Fig Joshua A Bueller Robert A Koeppe Jon-Kar Zubieta 《Neuropsychopharmacology》2007,61(9):1030-1038
BACKGROUND: Functional neuroimaging studies have detected abnormal limbic and paralimbic activation to emotional probes in posttraumatic stress disorder (PTSD), but few studies have examined neurochemical mechanisms that underlie functional alterations in regional cerebral blood flow. The mu-opioid neurotransmitter system, implicated in responses to stress and suppression of pain, is distributed in and is thought to regulate the function of brain regions that are implicated in affective processing. METHODS: Here we examined the micro-opioid system with positron emission tomography and the micro-opioid receptor-selective radiotracer [11C] carfentanil in 16 male patients with PTSD and two non-PTSD male control groups, with (n = 14) and without combat exposure (n = 15). Differences in micro-opioid receptor binding potential (BP2) were detected within discrete limbic and paralimbic regions. RESULTS: Relative to healthy controls, both trauma-exposed groups had lower micro-opioid receptor BP2 in extended amygdala, nucleus accumbens, and dorsal frontal and insular cortex but had higher BP2 in the orbitofrontal cortex. PTSD patients exhibited reduced BP2 in anterior cingulate cortex compared with both control groups. Micro-opioid receptor BP2 in combat-exposed subjects without PTSD was lower in the amygdala but higher in the orbitofrontal cortex compared with both PTSD patients and healthy controls. CONCLUSIONS: These findings differentiate the general response of the micro-opioid system to trauma from more specific changes associated with PTSD. 相似文献
5.
6.
7.
8.
Leonidas JC; Berdon WE; Valderrama E; Neveling U; Schuval S; Weiss SJ; Hilfer C; Godine L 《Radiology》1996,198(2):377
9.
10.
JC Sitek† M Loeb‡ JR Ronnevig¶ 《Journal of the European Academy of Dermatology and Venereology》2007,21(7):891-896
BACKGROUND: Since 1997, a number of trials have shown promising results in treating generalized vitiligo with narrowband ultraviolet B (UVB) both in adults and children. However, there is little knowledge concerning the duration and permanency of the treatment-induced repigmentation. OBJECTIVE: Our main objective was to perform a follow-up trial of successfully treated patients receiving narrowband UVB for generalized vitiligo. METHODS: We have investigated to what degree the treatment-induced repigmentation remains stable for up to 2 years post-treatment. We performed an initial open trial including 31 patients with generalized vitiligo. They received narrowband UVB thrice weekly for up to 12 months. Patients experiencing > 75% repigmentation were defined responders and were included in the follow-up trial. Responders were followed every 6 months for up to 2 years after cessation of treatment. We observed the pigmentation status and registered any changes indicating loss of pigmentation and relapse. RESULTS: Eleven of the 31 treated patients were included in the follow-up trial. Six patients had relapse and five patients had stable response 24 months after cessation of treatment. Four out of six relapses were within 6 months post-treatment. CONCLUSION: In our study population of 31 patients with generalized vitiligo, five patients (16%) experienced > 75% stable repigmentation 2 years after cessation of a treatment programme of up to 1 years narrowband UVB therapy. 相似文献